{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:7f0a4120-e452-4235-9611-192b3cfa4cc1","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-16T18:27:31.907294+00:00","published_at":"2026-10-16T13:52:50.363049+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:10n8ocgdbfdn6","event_type":"GC_CHANGED","effective_at":"2026-04-27","detected_at":"2026-10-16T13:52:50.363049+00:00","subject_ids":["alpha:person:brendan-o-malley","alpha:company:7f0a4120-e452-4235-9611-192b3cfa4cc1"],"caused_claim_ids":["alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:5b138bc3469f7bc49c5111ee29d91334e56d011c4068ac584352839848ab1331"],"summary":"Brendan O'Malley executive of ABEONA THERAPEUTICS INC., effective 2026-04-27.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:p6bze65hjmkk","event_type":"CFO_CHANGED","effective_at":"2026-04-27","detected_at":"2026-10-16T13:52:50.363049+00:00","subject_ids":["alpha:person:joseph-vazzano","alpha:company:7f0a4120-e452-4235-9611-192b3cfa4cc1"],"caused_claim_ids":["alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:15"],"evidence_ids":["alpha:projection-evidence:document:b890951581e1979438de2a1784b93aa1cb5b80ef5a35584ca7d555f4073167ee"],"summary":"Joseph Vazzano executive of ABEONA THERAPEUTICS INC., effective 2026-04-27.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:138ulznt3a1nx","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-04-27","detected_at":"2026-10-16T13:52:50.363049+00:00","subject_ids":["alpha:person:madhav-vasanthavada","alpha:company:7f0a4120-e452-4235-9611-192b3cfa4cc1"],"caused_claim_ids":["alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:16"],"evidence_ids":["alpha:projection-evidence:document:26ef7aab72d421c2c44b9918b801602a65aa8d23e4ffe0cce80d9e8d0e3219da"],"summary":"Madhav Vasanthavada executive of ABEONA THERAPEUTICS INC., effective 2026-04-27.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:dmpbto4fknk2","event_type":"CEO_CHANGED","effective_at":"2026-04-27","detected_at":"2026-10-16T13:52:50.363049+00:00","subject_ids":["alpha:person:vishwas-seshadri","alpha:company:7f0a4120-e452-4235-9611-192b3cfa4cc1"],"caused_claim_ids":["alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:17"],"evidence_ids":["alpha:projection-evidence:document:fe0e2a601d3e8e4b7c4a16b07caa611ed5f1a21940cb2c3f12b1c6ab80d1286d"],"summary":"Vishwas Seshadri executive of ABEONA THERAPEUTICS INC., effective 2026-04-27.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1adw7xufxlvwe","event_type":"DIRECTOR_APPOINTED","effective_at":"2024-01-01","detected_at":"2026-10-16T13:52:50.363049+00:00","subject_ids":["alpha:person:bernhardt-g-zeiher-m-d","alpha:company:7f0a4120-e452-4235-9611-192b3cfa4cc1"],"caused_claim_ids":["alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:aba2a994c7574d32bd328131d1d90abca896ce0ea8e9e65bc363c5857b70a3d7"],"summary":"Bernhardt G. Zeiher, M.D. seat on ABEONA THERAPEUTICS INC., effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1qsbaw97w3ouv","event_type":"DIRECTOR_APPOINTED","effective_at":"2024-01-01","detected_at":"2026-10-16T13:52:50.363049+00:00","subject_ids":["alpha:person:eric-crombez-m-d-2","alpha:company:7f0a4120-e452-4235-9611-192b3cfa4cc1"],"caused_claim_ids":["alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:aba2a994c7574d32bd328131d1d90abca896ce0ea8e9e65bc363c5857b70a3d7"],"summary":"Eric Crombez, M.D. seat on ABEONA THERAPEUTICS INC., effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1c512b71i5k0ut","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-16T13:52:50.363049+00:00","subject_ids":["alpha:person:donald-a-wuchterl","alpha:company:7f0a4120-e452-4235-9611-192b3cfa4cc1"],"caused_claim_ids":["alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:aba2a994c7574d32bd328131d1d90abca896ce0ea8e9e65bc363c5857b70a3d7"],"summary":"Donald A. Wuchterl seat on ABEONA THERAPEUTICS INC., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:kdn2snzo0lvj","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-16T13:52:50.363049+00:00","subject_ids":["alpha:person:faith-l-charles","alpha:company:7f0a4120-e452-4235-9611-192b3cfa4cc1"],"caused_claim_ids":["alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:aba2a994c7574d32bd328131d1d90abca896ce0ea8e9e65bc363c5857b70a3d7"],"summary":"Faith L. Charles seat on ABEONA THERAPEUTICS INC., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:s7az79r3mygj","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-16T13:52:50.363049+00:00","subject_ids":["alpha:person:leila-alland-m-d","alpha:company:7f0a4120-e452-4235-9611-192b3cfa4cc1"],"caused_claim_ids":["alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:aba2a994c7574d32bd328131d1d90abca896ce0ea8e9e65bc363c5857b70a3d7"],"summary":"Leila Alland, M.D. seat on ABEONA THERAPEUTICS INC., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1rejtri1biw6mm","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-16T13:52:50.363049+00:00","subject_ids":["alpha:person:mark-j-alvino","alpha:company:7f0a4120-e452-4235-9611-192b3cfa4cc1"],"caused_claim_ids":["alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:aba2a994c7574d32bd328131d1d90abca896ce0ea8e9e65bc363c5857b70a3d7"],"summary":"Mark J. Alvino seat on ABEONA THERAPEUTICS INC., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:nr1o9fnxt3e1","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-16T13:52:50.363049+00:00","subject_ids":["alpha:person:michael-amoroso","alpha:company:7f0a4120-e452-4235-9611-192b3cfa4cc1"],"caused_claim_ids":["alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:aba2a994c7574d32bd328131d1d90abca896ce0ea8e9e65bc363c5857b70a3d7"],"summary":"Michael Amoroso seat on ABEONA THERAPEUTICS INC., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1r5ujyq3eg1jk","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-16T13:52:50.363049+00:00","subject_ids":["alpha:person:vishwas-seshadri-ph-d","alpha:company:7f0a4120-e452-4235-9611-192b3cfa4cc1"],"caused_claim_ids":["alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:aba2a994c7574d32bd328131d1d90abca896ce0ea8e9e65bc363c5857b70a3d7"],"summary":"Vishwas Seshadri, Ph.D. seat on ABEONA THERAPEUTICS INC., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1t0gdb01rw090a","event_type":"COMMITTEE_CREATED","effective_at":"2021-01-01","detected_at":"2026-10-16T13:52:50.363049+00:00","subject_ids":["alpha:committee:abeona-therapeutics-inc:audit-chair-compensation-chair","alpha:company:7f0a4120-e452-4235-9611-192b3cfa4cc1"],"caused_claim_ids":["alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:aba2a994c7574d32bd328131d1d90abca896ce0ea8e9e65bc363c5857b70a3d7"],"summary":"Audit · Chair; Compensation · Chair committee of ABEONA THERAPEUTICS INC., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:76jwmf1sv3p4b","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2021-01-01","detected_at":"2026-10-16T13:52:50.363049+00:00","subject_ids":["alpha:person:mark-j-alvino","alpha:committee:abeona-therapeutics-inc:audit-chair-compensation-chair"],"caused_claim_ids":["alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:aba2a994c7574d32bd328131d1d90abca896ce0ea8e9e65bc363c5857b70a3d7"],"summary":"Mark J. Alvino member of Audit · Chair; Compensation · Chair, effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:17b9cml14g2a1t","event_type":"COMMITTEE_CREATED","effective_at":"2021-01-01","detected_at":"2026-10-16T13:52:50.363049+00:00","subject_ids":["alpha:committee:abeona-therapeutics-inc:audit-nominating-and-governance","alpha:company:7f0a4120-e452-4235-9611-192b3cfa4cc1"],"caused_claim_ids":["alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:aba2a994c7574d32bd328131d1d90abca896ce0ea8e9e65bc363c5857b70a3d7"],"summary":"Audit; Nominating and Governance committee of ABEONA THERAPEUTICS INC., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:pch40t1978pen","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2021-01-01","detected_at":"2026-10-16T13:52:50.363049+00:00","subject_ids":["alpha:person:donald-a-wuchterl","alpha:committee:abeona-therapeutics-inc:audit-nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:aba2a994c7574d32bd328131d1d90abca896ce0ea8e9e65bc363c5857b70a3d7"],"summary":"Donald A. Wuchterl member of Audit; Nominating and Governance, effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:msqz331gyrp1b","event_type":"COMMITTEE_CREATED","effective_at":"2021-01-01","detected_at":"2026-10-16T13:52:50.363049+00:00","subject_ids":["alpha:committee:abeona-therapeutics-inc:compensation-nominating-and-governance-chair","alpha:company:7f0a4120-e452-4235-9611-192b3cfa4cc1"],"caused_claim_ids":["alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:aba2a994c7574d32bd328131d1d90abca896ce0ea8e9e65bc363c5857b70a3d7"],"summary":"Compensation; Nominating and Governance · Chair committee of ABEONA THERAPEUTICS INC., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:5kzj8c1innuw8","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2021-01-01","detected_at":"2026-10-16T13:52:50.363049+00:00","subject_ids":["alpha:person:faith-l-charles","alpha:committee:abeona-therapeutics-inc:compensation-nominating-and-governance-chair"],"caused_claim_ids":["alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:aba2a994c7574d32bd328131d1d90abca896ce0ea8e9e65bc363c5857b70a3d7"],"summary":"Faith L. Charles member of Compensation; Nominating and Governance · Chair, effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:vyfcn919vfuap","event_type":"DIRECTOR_APPOINTED","effective_at":"2020-01-01","detected_at":"2026-10-16T13:52:50.363049+00:00","subject_ids":["alpha:person:christine-silverstein","alpha:company:7f0a4120-e452-4235-9611-192b3cfa4cc1"],"caused_claim_ids":["alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:aba2a994c7574d32bd328131d1d90abca896ce0ea8e9e65bc363c5857b70a3d7"],"summary":"Christine Silverstein seat on ABEONA THERAPEUTICS INC., effective 2020-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:5","subject_id":"alpha:company:7f0a4120-e452-4235-9611-192b3cfa4cc1","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:bernhardt-g-zeiher-m-d","object_label":"Bernhardt G. Zeiher, M.D.","object_source_name_forms":[],"value":"Bernhardt G. Zeiher, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:bernhardt-g-zeiher-m-d","name":"Bernhardt G. Zeiher, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-16T13:52:50.363049+00:00","sources":[{"id":"alpha:projection-evidence:document:aba2a994c7574d32bd328131d1d90abca896ce0ea8e9e65bc363c5857b70a3d7","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ABEONA THERAPEUTICS INC. DEF 14A 2025-04-09","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/318306/000164117225003411/formdef14a.htm","source_date":"2025-04-09","retrieved_at":"2026-04-24T20:11:02.895+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-09","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-16T13:52:50.363049+00:00","reviewed_at":"2026-10-16T13:52:50.363049+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:6","subject_id":"alpha:company:7f0a4120-e452-4235-9611-192b3cfa4cc1","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:christine-silverstein","object_label":"Christine Silverstein","object_source_name_forms":[],"value":"Christine Silverstein: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:christine-silverstein","name":"Christine Silverstein"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-16T13:52:50.363049+00:00","sources":[{"id":"alpha:projection-evidence:document:aba2a994c7574d32bd328131d1d90abca896ce0ea8e9e65bc363c5857b70a3d7","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ABEONA THERAPEUTICS INC. DEF 14A 2025-04-09","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/318306/000164117225003411/formdef14a.htm","source_date":"2025-04-09","retrieved_at":"2026-04-24T20:11:02.895+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-09","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-16T13:52:50.363049+00:00","reviewed_at":"2026-10-16T13:52:50.363049+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:7","subject_id":"alpha:company:7f0a4120-e452-4235-9611-192b3cfa4cc1","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:donald-a-wuchterl","object_label":"Donald A. Wuchterl","object_source_name_forms":[],"value":"Donald A. Wuchterl: Director, Audit; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:donald-a-wuchterl","name":"Donald A. Wuchterl"},"title":"Director","role_category":"director","committee":"Audit; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-16T13:52:50.363049+00:00","sources":[{"id":"alpha:projection-evidence:document:aba2a994c7574d32bd328131d1d90abca896ce0ea8e9e65bc363c5857b70a3d7","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ABEONA THERAPEUTICS INC. DEF 14A 2025-04-09","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/318306/000164117225003411/formdef14a.htm","source_date":"2025-04-09","retrieved_at":"2026-04-24T20:11:02.895+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-09","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-16T13:52:50.363049+00:00","reviewed_at":"2026-10-16T13:52:50.363049+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:8","subject_id":"alpha:company:7f0a4120-e452-4235-9611-192b3cfa4cc1","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:eric-crombez-m-d-2","object_label":"Eric Crombez, M.D.","object_source_name_forms":[],"value":"Eric Crombez, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:eric-crombez-m-d-2","name":"Eric Crombez, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-16T13:52:50.363049+00:00","sources":[{"id":"alpha:projection-evidence:document:aba2a994c7574d32bd328131d1d90abca896ce0ea8e9e65bc363c5857b70a3d7","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ABEONA THERAPEUTICS INC. DEF 14A 2025-04-09","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/318306/000164117225003411/formdef14a.htm","source_date":"2025-04-09","retrieved_at":"2026-04-24T20:11:02.895+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-09","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-16T13:52:50.363049+00:00","reviewed_at":"2026-10-16T13:52:50.363049+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:9","subject_id":"alpha:company:7f0a4120-e452-4235-9611-192b3cfa4cc1","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:faith-l-charles","object_label":"Faith L. Charles","object_source_name_forms":[],"value":"Faith L. Charles: Director, Compensation; Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:faith-l-charles","name":"Faith L. Charles"},"title":"Director","role_category":"director","committee":"Compensation; Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-16T13:52:50.363049+00:00","sources":[{"id":"alpha:projection-evidence:document:aba2a994c7574d32bd328131d1d90abca896ce0ea8e9e65bc363c5857b70a3d7","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ABEONA THERAPEUTICS INC. DEF 14A 2025-04-09","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/318306/000164117225003411/formdef14a.htm","source_date":"2025-04-09","retrieved_at":"2026-04-24T20:11:02.895+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-09","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-16T13:52:50.363049+00:00","reviewed_at":"2026-10-16T13:52:50.363049+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:10","subject_id":"alpha:company:7f0a4120-e452-4235-9611-192b3cfa4cc1","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:leila-alland-m-d","object_label":"Leila Alland, M.D.","object_source_name_forms":[],"value":"Leila Alland, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:leila-alland-m-d","name":"Leila Alland, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-16T13:52:50.363049+00:00","sources":[{"id":"alpha:projection-evidence:document:aba2a994c7574d32bd328131d1d90abca896ce0ea8e9e65bc363c5857b70a3d7","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ABEONA THERAPEUTICS INC. DEF 14A 2025-04-09","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/318306/000164117225003411/formdef14a.htm","source_date":"2025-04-09","retrieved_at":"2026-04-24T20:11:02.895+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-09","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-16T13:52:50.363049+00:00","reviewed_at":"2026-10-16T13:52:50.363049+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:11","subject_id":"alpha:company:7f0a4120-e452-4235-9611-192b3cfa4cc1","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:mark-j-alvino","object_label":"Mark J. Alvino","object_source_name_forms":[],"value":"Mark J. Alvino: Director, Audit · Chair; Compensation · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:mark-j-alvino","name":"Mark J. Alvino"},"title":"Director","role_category":"director","committee":"Audit · Chair; Compensation · Chair","is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-16T13:52:50.363049+00:00","sources":[{"id":"alpha:projection-evidence:document:aba2a994c7574d32bd328131d1d90abca896ce0ea8e9e65bc363c5857b70a3d7","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ABEONA THERAPEUTICS INC. DEF 14A 2025-04-09","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/318306/000164117225003411/formdef14a.htm","source_date":"2025-04-09","retrieved_at":"2026-04-24T20:11:02.895+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-09","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-16T13:52:50.363049+00:00","reviewed_at":"2026-10-16T13:52:50.363049+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:12","subject_id":"alpha:company:7f0a4120-e452-4235-9611-192b3cfa4cc1","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:michael-amoroso","object_label":"Michael Amoroso","object_source_name_forms":[],"value":"Michael Amoroso: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:michael-amoroso","name":"Michael Amoroso"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-16T13:52:50.363049+00:00","sources":[{"id":"alpha:projection-evidence:document:aba2a994c7574d32bd328131d1d90abca896ce0ea8e9e65bc363c5857b70a3d7","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ABEONA THERAPEUTICS INC. DEF 14A 2025-04-09","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/318306/000164117225003411/formdef14a.htm","source_date":"2025-04-09","retrieved_at":"2026-04-24T20:11:02.895+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-09","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-16T13:52:50.363049+00:00","reviewed_at":"2026-10-16T13:52:50.363049+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:13","subject_id":"alpha:company:7f0a4120-e452-4235-9611-192b3cfa4cc1","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:vishwas-seshadri-ph-d","object_label":"Vishwas Seshadri, Ph.D.","object_source_name_forms":[],"value":"Vishwas Seshadri, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:vishwas-seshadri-ph-d","name":"Vishwas Seshadri, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-16T13:52:50.363049+00:00","sources":[{"id":"alpha:projection-evidence:document:aba2a994c7574d32bd328131d1d90abca896ce0ea8e9e65bc363c5857b70a3d7","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ABEONA THERAPEUTICS INC. DEF 14A 2025-04-09","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/318306/000164117225003411/formdef14a.htm","source_date":"2025-04-09","retrieved_at":"2026-04-24T20:11:02.895+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-09","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-16T13:52:50.363049+00:00","reviewed_at":"2026-10-16T13:52:50.363049+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:14","subject_id":"alpha:company:7f0a4120-e452-4235-9611-192b3cfa4cc1","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:brendan-o-malley","object_label":"Brendan O'Malley","object_source_name_forms":[],"value":"Brendan O'Malley: Chief Legal Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:brendan-o-malley","name":"Brendan O'Malley"},"title":"Chief Legal Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-27","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-27","valid_to":null,"recorded_at":"2026-10-16T13:52:50.363049+00:00","sources":[{"id":"alpha:projection-evidence:document:5b138bc3469f7bc49c5111ee29d91334e56d011c4068ac584352839848ab1331","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ABEO DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226019153/formdef14a.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-05-15T22:02:02.729217+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":"2026-04-27","effective_until":null,"observed_at":"2026-10-16T13:52:50.363049+00:00","reviewed_at":"2026-10-16T13:52:50.363049+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:15","subject_id":"alpha:company:7f0a4120-e452-4235-9611-192b3cfa4cc1","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:joseph-vazzano","object_label":"Joseph Vazzano","object_source_name_forms":[],"value":"Joseph Vazzano: Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:joseph-vazzano","name":"Joseph Vazzano"},"title":"Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-27","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-27","valid_to":null,"recorded_at":"2026-10-16T13:52:50.363049+00:00","sources":[{"id":"alpha:projection-evidence:document:b890951581e1979438de2a1784b93aa1cb5b80ef5a35584ca7d555f4073167ee","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ABEO DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226019153/formdef14a.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-05-15T22:02:02.253916+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":"2026-04-27","effective_until":null,"observed_at":"2026-10-16T13:52:50.363049+00:00","reviewed_at":"2026-10-16T13:52:50.363049+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:16","subject_id":"alpha:company:7f0a4120-e452-4235-9611-192b3cfa4cc1","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:madhav-vasanthavada","object_label":"Madhav Vasanthavada","object_source_name_forms":[],"value":"Madhav Vasanthavada: Chief Commercial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:madhav-vasanthavada","name":"Madhav Vasanthavada"},"title":"Chief Commercial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-27","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-27","valid_to":null,"recorded_at":"2026-10-16T13:52:50.363049+00:00","sources":[{"id":"alpha:projection-evidence:document:26ef7aab72d421c2c44b9918b801602a65aa8d23e4ffe0cce80d9e8d0e3219da","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ABEO DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226019153/formdef14a.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-05-15T22:02:03.194121+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":"2026-04-27","effective_until":null,"observed_at":"2026-10-16T13:52:50.363049+00:00","reviewed_at":"2026-10-16T13:52:50.363049+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:7f0a4120-e452-4235-9611-192b3cfa4cc1:leadership_role:17","subject_id":"alpha:company:7f0a4120-e452-4235-9611-192b3cfa4cc1","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:vishwas-seshadri","object_label":"Vishwas Seshadri","object_source_name_forms":[],"value":"Vishwas Seshadri: President and Chief Executive Officer and Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:vishwas-seshadri","name":"Vishwas Seshadri"},"title":"President and Chief Executive Officer and Director","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-27","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-27","valid_to":null,"recorded_at":"2026-10-16T13:52:50.363049+00:00","sources":[{"id":"alpha:projection-evidence:document:fe0e2a601d3e8e4b7c4a16b07caa611ed5f1a21940cb2c3f12b1c6ab80d1286d","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ABEO DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226019153/formdef14a.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-05-15T22:02:01.767036+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-27T00:00:00+00:00","effective_from":"2026-04-27","effective_until":null,"observed_at":"2026-10-16T13:52:50.363049+00:00","reviewed_at":"2026-10-16T13:52:50.363049+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:aba2a994c7574d32bd328131d1d90abca896ce0ea8e9e65bc363c5857b70a3d7","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"ABEONA THERAPEUTICS INC. DEF 14A 2025-04-09","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/318306/000164117225003411/formdef14a.htm","source_date":"2025-04-09","retrieved_at":"2026-04-24T20:11:02.895+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:5b138bc3469f7bc49c5111ee29d91334e56d011c4068ac584352839848ab1331","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ABEO DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226019153/formdef14a.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-05-15T22:02:02.729217+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:b890951581e1979438de2a1784b93aa1cb5b80ef5a35584ca7d555f4073167ee","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ABEO DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226019153/formdef14a.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-05-15T22:02:02.253916+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:26ef7aab72d421c2c44b9918b801602a65aa8d23e4ffe0cce80d9e8d0e3219da","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ABEO DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226019153/formdef14a.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-05-15T22:02:03.194121+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:fe0e2a601d3e8e4b7c4a16b07caa611ed5f1a21940cb2c3f12b1c6ab80d1286d","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ABEO DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226019153/formdef14a.htm","source_date":"2026-04-27T00:00:00+00:00","retrieved_at":"2026-05-15T22:02:01.767036+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.844,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.9,"cross_source_agreement":0.75,"temporal_completeness":0.684},"diagnostics":{"published_claims":26,"factual_claims":26,"claims_with_linked_evidence":26,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":19,"temporal_claims_with_valid_from":13,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-16T13:52:50.363049+00:00","observed_at":"2026-10-16T13:52:50.363049+00:00","reviewed_at":"2026-10-16T13:52:50.363049+00:00","verified_at":"2026-10-16T13:52:50.363049+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":26,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/abeona-therapeutics-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/abeona-therapeutics-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}